Search Within

Joachim Yahalom

  1. "Parastoo Dahi"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (7)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (27)
  2. CTCR Scholars (27)
  3. Center for Hematologic Malignancies (27)
  4. Department of Medicine (27)
  5. Hematologic Malignancies, Division of (27)
  6. MSK Grad Students (27)

More Groups

People
  1. Parastoo Dahi (27)
  2. Brandon Imber (25)
  3. Gunjan Shah (25)
  4. Miguel-Angel Perales (25)
  5. Maria Palomba (24)
  6. Michael Scordo (24)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (3)
  6. 2020 (5)

More Years

Publications
  1. Blood (9)
  2. International Journal of Radiation Oncology, Biology, Physics (4)
  3. Hematological Oncology (3)
  4. Transplantation and Cellular Therapy (3)
  5. Blood Advances (2)
  6. Leukemia and Lymphoma (2)

More Publications

Publishers
  1. American Society of Hematology (11)
  2. Elsevier Inc. (7)
  3. Wiley Blackwell (3)
  4. Taylor & Francis Group (2)
  5. American Association for Cancer Research (1)
  6. John Wiley & Sons (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population
    Journal Article

    Ghione, P.; Qi, S.; Imber, B. S.; Seshan, V.; Moskowitz, A.; Galasso, N.; Lunning, M.; Straus, D.; Sauter, C.; Dahi, P.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
    Journal Article

    Imber, B. S.; Sadelain, M.; DeSelm, C.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Giralt, S.; Park, J. H.; Sauter, C.; Scordo, M.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; DeSelm, C.; Batlevi, C.; Dahi, P. B.; Giralt, S.; Noy, A. M.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save